I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
How can patient preferences be used and communicated in the..:
Rosanne Janssens
;
Liese Barbier
;
Mireille Muller
...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1192770/full. , 2023
Link:
https://doi.org/10.3389/fphar.2023.1192770
RT Journal T1
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:805a297780d245ba87369a0bda9aa40c&Exemplar=1&LAN=DE A1 Rosanne Janssens A1 Liese Barbier A1 Mireille Muller A1 Irina Cleemput A1 Isabelle Stoeckert A1 Chiara Whichello A1 Bennett Levitan A1 Tarek A. Hammad A1 Charis Girvalaki A1 Juan-Jose Ventura A1 Karin Schölin Bywall A1 Cathy Anne Pinto A1 Elise Schoefs A1 Eva G. Katz A1 Ulrik Kihlbom A1 Isabelle Huys PB Frontiers Media S.A. YR 2023 K1 patient preferences K1 patient experience data K1 regulatory evaluation K1 scientific advice K1 benefit-risk assessment K1 clinical trial endpoint selection K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2023.1192770/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2023.1192770 DO https://doi.org/10.3389/fphar.2023.1192770 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)